ROSE MEDICAL CENTER — History
CCN 060032 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$347M
Latest Revenue (FY2022)
+4.7%
Revenue CAGR (3yr)
22.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $317M | $345M | $347M | +0.6% | +4.7% |
| Operating Expenses | $238M | $260M | $271M | +4.4% | +6.8% |
| Operating Margin | 25.0% | 24.8% | 22.0% | -11.4% | -6.2% |
| Net Income | $79M | $86M | $76M | -10.9% | -1.8% |
| Licensed Beds | 217 | 249 | 253 | +1.6% | +8.0% |
| Total Patient Days | 49,185 | 50,608 | 50,112 | -1.0% | +0.9% |
| Medicare Day % | 16% | 15% | 13% | -11.7% | -9.7% |
| Medicaid Day % | 18% | 17% | 23% | +36.0% | +13.7% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +9.6% ($317M → $347M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.7%
This Hospital
+7.6%
State Avg
Latest Margin
22.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $362M | 20.5% |
| FY2024 (proj) | $378M | 19.0% |
| FY2025 (proj) | $393M | 17.5% |